Jean‐Philippe Ryckelynck

Author

Hôpital Georges-Clemenceau

Also Known As

Guillaume Jean, Jean-Philippe Ryckelynck, Jean‐Philippe Ryckelynck, Ryckelynck, Jean-Philippe

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Hôpital Georges-Clemenceau Université de Caen Normandie Centre Hospitalier Régional et Universitaire de Nancy Leicester General Hospital

About

Jean‐Philippe Ryckelynck is an author at Hôpital Georges-Clemenceau specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	341
2	Public Health	1	1	48
3	Emergency Medicine	1	1	26
4	Health Policy	1	1	48
5	Immunology	1	1	27

Jean‐Philippe Ryckelynck

Publications

874

Citations

H-Index

Page 1

	Year	Citations
Once-Monthly Subcutaneous C.E.R.A. Maintains Stable Hemoglobin Control in Patients with Chronic Kidney Disease on Dialysis and Converted Directly from Epoetin One to Three Times Weekly Francesco Locatelli, Jean‐Philippe Ryckelynck, József Balla, Clinical Journal of the American Society of Nephrology	2007	137
Is Assisted Peritoneal Dialysis Associated with Technique Survival When Competing Events Are Considered? Thierry Lobbedez, Christian Verger, Jean‐Philippe Ryckelynck, Clinical Journal of the American Society of Nephrology	2012	114
Assisted Peritoneal Dialysis. Experience in a French Renal Department Thierry Lobbedez, Raluca Moldovan, Marie Lecame, Peritoneal Dialysis International	2006	112
The Referral Pattern of Patients with Esrd is a Determinant in the Choice of Dialysis Modality Norbert Lameire, Wim Van Biesen, Nicholas Dombros, Peritoneal Dialysis International HemodialysisUrologyRenal DiseaseReferral PatternRenal Function	1997	80
Clinical Pharmacokinetics of Ketoprofen After Single Intravenous Administration as a Bolus or Infusion Danièle Debruyne, Bruno Hurault de Ligny, Jean‐Philippe Ryckelynck, Clinical Pharmacokinetics Single Intravenous AdministrationLocal PharmacologyPharmacologyPharmacotherapyClinical Pharmacokinetics	1987	51
Access to, and outcome of, renal transplantation according to treatment modality of end-stage renal disease in France Ylana Chalem, Jean‐Philippe Ryckelynck, Philippe Tuppin, Kidney International Transplantation SurgeryGlomerulonephritisUrologyRenal DiseaseTransplantation	2005	48
Variability in Case Mix and Peritoneal Dialysis Selection in Fifty-Nine French Districts Cécile Couchoud, Émilie Savoye, Luc Frimat, Peritoneal Dialysis International DialysisFirst ModalityDialysis TherapyPublic HealthChronic Kidney Disease	2008	48
Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD Sophie Liabeuf, Jean‐Philippe Ryckelynck, N. El Esper, Clinical Journal of the American Society of Nephrology	2017	48
Is Peritonitis Risk Increased in Elderly Patients on Peritoneal Dialysis? Report from the French Language Peritoneal Dialysis Registry (RDPLF) Simon Duquennoy, Clémence Bechade, Christian Verger, Peritoneal Dialysis International	2015	47
Pharmacokinetics of Fluconazole in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis Danièle Debruyne, Jean‐Philippe Ryckelynck, Maurice Moulin, Clinical Pharmacokinetics HemodialysisMedicineKidney FailurePharmacologyDialysis Therapy	1990	44

Page 1